skip to main | skip to sidebar

THE AMPYRA CHANNEL

NEWS & TIPS!

Tuesday


People Petition For Fampyra to Become a Subsidized Drug in Australia

Posted by Josi Creek Mackenzie Miller at 6:59 PM
Newer Post Older Post Home

Blog Archive

  • ►  2016 (8)
    • ►  May (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2015 (16)
    • ►  July (1)
    • ►  June (3)
    • ►  March (1)
    • ►  February (1)
    • ►  January (10)
  • ▼  2014 (42)
    • ▼  April (41)
      • AMPYRA IMPROVES STANDING BALANCE
      • "Researchers don’t know why some multiple sclerosi...
      • Researchers don’t know why some multiple sclerosis...
      • Biogen Idec to Present New Clinical Data from Its ...
      • Next Chapter In The Acorda Story Will Be A Page Tu...
      • Central motor conduction time may predict response...
      • Study: AMPYRA IMPROVES WALKING FOR MSers
      • It's no wonder MS is seen as a Cash Cow: THESE MS ...
      • People Petition For Fampyra to Become a Subsidized...
      • Jennifer Landry, Columnist, MSnewsChannel.com
      • Biogen Idec and UCB Enter Agreements to Commercial...
      • AMPYRA (dalfampridine) 2014 Net Sales Guidance of ...
      • Tecfidera and Ampyra Show Potential for Quality of...
      • Tecfidera & Ampyra Show Potential for Quality of L...
      • STUDY: AMPYRA (Dalfampridine) improves walking spe...
      • Treatment with dalfampridine (AMPYRA) resulted in ...
      • VIDEO: Ampyra helps MS patients to walk again
      • Acorda Therapeutics (Amprya) Recognized by Nationa...
      • BERLENA HAS PHOTOS & AN AMAZING STORY ABOUT HOW AM...
      • Extension Data Show Dalfampridine (Amprya) Continu...
      • The Answers to Frequently Asked Questions About Am...
      • AAN:Acorda’s Ampyra Runs Ahead of Other Multiple S...
      • Acorda Therapeutics Announces Data On AMPYRA™ (dal...
      • Acorda Therapeutics Announces Data on AMPYRA(TM) (...
      • Research Advocate: Ampyra Approved by FDA to Impro...
      • New Multiple Sclerosis drug culminates researchers...
      • Clinical Benefit of Multiple Sclerosis Drug Discov...
      • "the neuro said he will start me on Ampyra, the wa...
      • Ampyra is First Symptom Management Drug Developed ...
      • Acorda Therapeutics Announces Filing of Patent Ext...
      • Acorda deals MS med direct to patients
      • An upbeat MS update
      • MS Learn Online with videos on Ampyra, Med. Mariju...
      • Ampyra (the new walking pill) - Acorda Therapeutic...
      • New Multiple Sclerosis Drug
      • Acorda launches Ampyra ER tablets in US & Puerto R...
      • New drug could improve walking ability of people w...
      • Drug helps MS patients with mobility problems
      • NMSS Video on Ampyra,New MS "Walking" Drug
      • MS Drug Ampyra Gets FDA Nod
      • New Oral MS Drug
    • ►  February (1)
  • ►  2013 (12)
    • ►  October (7)
    • ►  September (2)
    • ►  July (2)
    • ►  May (1)
  • ►  2010 (26)
    • ►  May (1)
    • ►  April (13)
    • ►  March (12)